Evidence map›Paper›PMID 20484820›Full record

ArticleThe Journal of clinical investigation2010

PET probes for distinct metabolic pathways have different cell specificities during immune responses in mice.

Evan Nair-Gill, Stephanie M Wiltzius, Xiao X Wei, Donghui Cheng, Mireille Riedinger, Caius G Radu, Owen N Witte

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 46 citations in OpenAlex.

  1. RadioFlow Cytometry Reveals That [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  2. FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2020
    Article
  8. Review
  9. Review
  10. Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2018
    Article
  11. [Theranostics · 2018
    Article
  12. Detection of immune responses after immunotherapy in glioblastoma using PET and MRI.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  13. Review
  14. Harnessing Preclinical Molecular Imaging to Inform Advances in Personalized Cancer Medicine.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2017
    Review
  15. Article
  16. [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  17. Review
  18. Article
  19. Immuno-PET of Murine T Cell Reconstitution Postadoptive Stem Cell Transplantation Using Anti-CD4 and Anti-CD8 Cys-Diabodies.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2015
    Article
  20. Targeted noninvasive imaging of the innate immune response.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Evan Nair-GillDepartment of Molecular and Medical Pharmacology, UCLA, Los Angeles, California, USA.
Stephanie M Wiltzius
Xiao X Wei
Donghui Cheng
Mireille Riedinger
Caius G Radu
Owen N Witte
Howard Hughes Medical Institute · USUniversity of California, Los Angeles · US

Funding

UCLA-Caltech Medical Scientist Training ProgramT32GM008042 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI AJIJOLA, OLUJIMI A, DAWSON, DAVID WAYNE · 1985 to 2023
$29.9M
Transductionally Redirected /Transcriptionally RestricteP50CA086306 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HERSCHMAN, HARVEY R. · 2000 to 2014
$29.0M
QUANTITATIVE IMAGE ANALYSIS SPECIALIZED RESOURCE COREU54CA119347 · NCI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI HEATH, JAMES R. · 2005 to 2009
$17.8M
Howard Hughes Medical InstituteNCI NIH HHS 5U54 CA119347NCI NIH HHS P50 CA086306NCI NIH HHS P50 CA86306NCI NIH HHS U54 CA119347NIGMS NIH HHS T32 GM008042NIGMS NIH HHS T32 GM08042PHS HHS T32 A1065067
6 · The paper itself

Abstract

Clinical tools that measure changes in immune cell metabolism would improve the diagnosis and treatment of immune dysfunction. PET, utilizing probes for specific metabolic processes, detects regions of immune activation in vivo. In this study we investigated the immune cell specificity of PET probes for two different metabolic pathways: [18F]-2-fluorodeoxyglucose ([18F]-FDG) for glycolysis and [18F]-2-fluoro-D-(arabinofuranosyl)cytosine ([18F]-FAC) for deoxycytidine salvage. We isolated innate and adaptive immune cells from tissues of mice challenged with a retrovirus-induced sarcoma and measured their ability to accumulate FDG and FAC. We determined that the two probes had distinct patterns of accumulation: FDG accumulated to the highest levels in innate immune cells, while FAC accumulated predominantly in CD8+ T cells in a manner that correlated with cellular proliferation. This study demonstrates that innate and adaptive cell types differ in glycolytic and deoxycytidine salvage demands during an immune response and that these differential metabolic requirements can be detected with specific PET probes. Our findings have implications for the interpretation of clinical PET scans that use [18F]-FDG or [18F]-FAC to assess immune function in vivo and suggest potential applications of metabolic PET to monitor the effects of targeted immune modulation.

Indexed as

Immune System PhenomenaMetabolic Networks and PathwaysAnimalsCell ProliferationCellsCellular StructuresFluorodeoxyglucose F18MaleMiceMice, Inbred C57BLMice, SCIDPositron-Emission TomographySensitivity and SpecificityFluorodeoxyglucose F18

Identifiers

PMID20484820
PMCPMC2877561
OpenAlexW2092328603

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.